Evidence map›Paper›PMID 30911535›Full record

ArticleClinical and translational imaging2018

Thyroid Cancer Radiotheragnostics: the case for activity adjusted

Anca M Avram, Yuni K Dewaraja

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Advances in Radioligand Theranostics in Oncology.Molecular diagnosis & therapy · 2024
    Review
  3. Nuclear Medicine and Cancer Theragnostics: Basic Concepts.Diagnostics (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Anca M AvramDivision of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Yuni K DewarajaDivision of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
University of Michigan–Ann Arbor · US

Funding

SPECT/CT Image-Based Dosimetry in Radionuclide TharapyR01EB001994 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2003 to 2014
$3.9M
NIBIB NIH HHS R01 EB001994
6 · The paper itself

Abstract

Radiotheragnostics represents the systematic integration of diagnostic imaging and therapeutics using radionuclides targeting specific characteristics of tumor biology. Radioiodine (

Indexed as

131I SPECT/CT131I therapydiagnostic radioiodine scandifferentiated thyroid cancerRadiotheragnosticstheragnostics

Identifiers

PMID30911535
PMCPMC6430577
OpenAlexW2887401669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.